Rare Drosha splice variants are deficient in microRNA processing but do not affect general microRNA expression in...

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• Drosha is essential for microRNA (miRNA) biogenesis, processing primary transcripts (pri-miRNA) into precursor miRNAs (pre-miRNA).
• DGCR8 binding partner dictates Drosha's specificity and cleavage site, crucial for efficient miRNA production.
• Key Drosha domains include RNase III domains (RIIID) and a C-terminal dsRNA binding domain (dsRBD).

Purpose of the Study:

• To identify and characterize alternatively spliced Drosha transcripts in human melanoma and NT2 cell lines.
• To investigate the functional consequences of these splice variants on DGCR8 binding and pri-miRNA processing.
• To explore the potential role of these variants in miRNA deregulation in cancer.

Main Methods:

• Identification of alternatively spliced transcripts using human melanoma and NT2 cell lines.
• Analysis of Drosha protein variants' binding affinity to DGCR8 and Ewing sarcoma protein (EWS).
• In vitro and in vivo assays to assess pri-miRNA processing efficiency of Drosha splice variants.

Main Results:

• Alternatively spliced Drosha transcripts encoding C-terminally truncated proteins were identified.
• These truncated Drosha variants lack DGCR8 binding but retain EWS interaction.
• The Drosha splice variants exhibited deficiencies in pri-miRNA processing both in vitro and in vivo.
• Aberrant transcripts did not consistently correlate with reduced mature miRNA levels in melanoma cells, possibly due to low abundance.

Conclusions:

• Alternative, processing-deficient Drosha splice variants are present in human melanoma cells.
• Elevated levels of these variants could represent a mechanism for miRNA deregulation in cancer.
• Searching for similar inactive splice variants in other tumor types may elucidate decreased miRNA processing in cancer.